"Líder en Técnicas de Reproducción Asistida. Fertilidad"

During the past decade, Halitus Instituto Médico conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Halitus Instituto Médico" are "Psoriasis" (2 trials). Many other conditions were trialed in "Halitus Instituto Médico" in a lesser frequency.

Most popular intervention types in "Halitus Instituto Médico" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (2 trials), "Placebo" (1 trials) and "Secukinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Halitus Instituto Médico" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Halitus Instituto Médico". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Halitus Instituto Médico, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Halitus Instituto Médico, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".